Monday, 30 September 2019

DCGI took measures on Ranitidine contamination to ensure patient safety

DCGI asked manufacturers of Ranitidine API & formulations to verify their products and take appropriate measures to ensure patient safety after news of ranitidine contamination came in picture.

 



source https://www.pharmatutor.org/pharma-news/2019/dcgi-took-measures-on-ranitidine-contamination-to-ensure-patient-safety
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Career for Pharmacy and Biotech at National Agri-Food and Biomanufacturing Institute

Positions: Junior Research Fellow (JRF) (One) Master’s Degree from a recognized University/Institute in M.Sc. Chemistry - Organic / Physical...